Late-onset NPM1 mutation in a MYC-amplified relapsed/refractory acute myeloid leukemia patient treated with gemtuzumab ozogamicin and glasdegib

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Jaramillo Segura, Sonia (VerfasserIn) , Scherer, Michael (VerfasserIn) , Szu-Tu, Chelsea (VerfasserIn) , Beneyto-Calabuig, Sergi (VerfasserIn) , Müller-Tidow, Carsten (VerfasserIn) , Schlenk, Richard Friedrich (VerfasserIn) , Hundemer, Michael (VerfasserIn) , Velten, Lars (VerfasserIn) , Pabst, Caroline (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: November, 2024
In: Haematologica
Year: 2024, Jahrgang: 109, Heft: 11, Pages: 3811-3815
ISSN:1592-8721
DOI:10.3324/haematol.2023.284922
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.3324/haematol.2023.284922
Verlag, kostenfrei, Volltext: https://haematologica.org/article/view/haematol.2023.284922
Volltext
Verfasserangaben:Sonia Jaramillo, Michael Scherer, Chelsea Szu-Tu, Sergi Beneyto-Calabuig, Carsten Müller-Tidow, Richard F. Schlenk, Michael Hundemer, Lars Velten and Caroline Pabst

MARC

LEADER 00000naa a2200000 c 4500
001 1927251044
003 DE-627
005 20250602122849.0
007 cr uuu---uuuuu
008 250602s2024 xx |||||o 00| ||eng c
024 7 |a 10.3324/haematol.2023.284922  |2 doi 
035 |a (DE-627)1927251044 
035 |a (DE-599)KXP1927251044 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Jaramillo Segura, Sonia  |e VerfasserIn  |0 (DE-588)1149855606  |0 (DE-627)1010162772  |0 (DE-576)496412213  |4 aut 
245 1 0 |a Late-onset NPM1 mutation in a MYC-amplified relapsed/refractory acute myeloid leukemia patient treated with gemtuzumab ozogamicin and glasdegib  |c Sonia Jaramillo, Michael Scherer, Chelsea Szu-Tu, Sergi Beneyto-Calabuig, Carsten Müller-Tidow, Richard F. Schlenk, Michael Hundemer, Lars Velten and Caroline Pabst 
246 3 3 |a Late-onset NPMone mutation in a MYC-amplified relapsed/refractory acute myeloid leukemia patient treated with gemtuzumab ozogamicin and glasdegib 
264 1 |c November, 2024 
300 |b Illustrationen 
300 |a 5 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 02.06.2025 
700 1 |a Scherer, Michael  |e VerfasserIn  |4 aut 
700 1 |a Szu-Tu, Chelsea  |e VerfasserIn  |4 aut 
700 1 |a Beneyto-Calabuig, Sergi  |e VerfasserIn  |4 aut 
700 1 |a Müller-Tidow, Carsten  |d 1968-  |e VerfasserIn  |0 (DE-588)1015101798  |0 (DE-627)705330230  |0 (DE-576)351197893  |4 aut 
700 1 |a Schlenk, Richard Friedrich  |d 1965-  |e VerfasserIn  |0 (DE-588)129025380  |0 (DE-627)387778004  |0 (DE-576)297454102  |4 aut 
700 1 |a Hundemer, Michael  |d 1972-  |e VerfasserIn  |0 (DE-588)128390549  |0 (DE-627)372634001  |0 (DE-576)297117998  |4 aut 
700 1 |a Velten, Lars  |e VerfasserIn  |4 aut 
700 1 |a Pabst, Caroline  |d 1981-  |e VerfasserIn  |0 (DE-588)136164668  |0 (DE-627)577203819  |0 (DE-576)284653667  |4 aut 
773 0 8 |i Enthalten in  |t Haematologica  |d Pavia : Ferrata Storti Foundation, 2014  |g 109(2024), 11 vom: Nov., Seite 3811-3815  |h Online-Ressource  |w (DE-627)814204899  |w (DE-600)2805244-4  |w (DE-576)424051125  |x 1592-8721  |7 nnas  |a Late-onset NPM1 mutation in a MYC-amplified relapsed/refractory acute myeloid leukemia patient treated with gemtuzumab ozogamicin and glasdegib 
773 1 8 |g volume:109  |g year:2024  |g number:11  |g month:11  |g pages:3811-3815  |g extent:5  |a Late-onset NPM1 mutation in a MYC-amplified relapsed/refractory acute myeloid leukemia patient treated with gemtuzumab ozogamicin and glasdegib 
856 4 0 |u https://doi.org/10.3324/haematol.2023.284922  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://haematologica.org/article/view/haematol.2023.284922  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20250602 
993 |a Article 
994 |a 2024 
998 |g 136164668  |a Pabst, Caroline  |m 136164668:Pabst, Caroline  |d 910000  |d 910100  |e 910000PP136164668  |e 910100PP136164668  |k 0/910000/  |k 1/910000/910100/  |p 9  |y j 
998 |g 128390549  |a Hundemer, Michael  |m 128390549:Hundemer, Michael  |d 910000  |d 910100  |d 50000  |e 910000PH128390549  |e 910100PH128390549  |e 50000PH128390549  |k 0/910000/  |k 1/910000/910100/  |k 0/50000/  |p 7 
998 |g 129025380  |a Schlenk, Richard Friedrich  |m 129025380:Schlenk, Richard Friedrich  |d 910000  |d 910100  |e 910000PS129025380  |e 910100PS129025380  |k 0/910000/  |k 1/910000/910100/  |p 6 
998 |g 1015101798  |a Müller-Tidow, Carsten  |m 1015101798:Müller-Tidow, Carsten  |d 910000  |d 910100  |e 910000PM1015101798  |e 910100PM1015101798  |k 0/910000/  |k 1/910000/910100/  |p 5 
998 |g 1149855606  |a Jaramillo Segura, Sonia  |m 1149855606:Jaramillo Segura, Sonia  |p 1  |x j 
999 |a KXP-PPN1927251044  |e 4729852591 
BIB |a Y 
SER |a journal 
JSO |a {"titleAlt":[{"title":"Late-onset NPMone mutation in a MYC-amplified relapsed/refractory acute myeloid leukemia patient treated with gemtuzumab ozogamicin and glasdegib"}],"name":{"displayForm":["Sonia Jaramillo, Michael Scherer, Chelsea Szu-Tu, Sergi Beneyto-Calabuig, Carsten Müller-Tidow, Richard F. Schlenk, Michael Hundemer, Lars Velten and Caroline Pabst"]},"id":{"doi":["10.3324/haematol.2023.284922"],"eki":["1927251044"]},"person":[{"display":"Jaramillo Segura, Sonia","role":"aut","given":"Sonia","family":"Jaramillo Segura"},{"family":"Scherer","role":"aut","given":"Michael","display":"Scherer, Michael"},{"display":"Szu-Tu, Chelsea","family":"Szu-Tu","role":"aut","given":"Chelsea"},{"display":"Beneyto-Calabuig, Sergi","family":"Beneyto-Calabuig","given":"Sergi","role":"aut"},{"role":"aut","given":"Carsten","family":"Müller-Tidow","display":"Müller-Tidow, Carsten"},{"family":"Schlenk","role":"aut","given":"Richard Friedrich","display":"Schlenk, Richard Friedrich"},{"display":"Hundemer, Michael","given":"Michael","role":"aut","family":"Hundemer"},{"display":"Velten, Lars","given":"Lars","role":"aut","family":"Velten"},{"role":"aut","given":"Caroline","family":"Pabst","display":"Pabst, Caroline"}],"relHost":[{"pubHistory":["99.2014 -"],"titleAlt":[{"title":"journal of the European Hematology Association"}],"id":{"zdb":["2805244-4"],"eki":["814204899"],"issn":["1592-8721"]},"part":{"volume":"109","year":"2024","extent":"5","text":"109(2024), 11 vom: Nov., Seite 3811-3815","issue":"11","pages":"3811-3815"},"recId":"814204899","physDesc":[{"extent":"Online-Ressource"}],"disp":"Late-onset NPM1 mutation in a MYC-amplified relapsed/refractory acute myeloid leukemia patient treated with gemtuzumab ozogamicin and glasdegibHaematologica","origin":[{"dateIssuedKey":"2014","dateIssuedDisp":"2014-","publisherPlace":"Pavia","publisher":"Ferrata Storti Foundation"}],"title":[{"subtitle":"journal of the European Hematology Association : journal of the Ferrata Storti Foundation","title":"Haematologica","title_sort":"Haematologica"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"language":["eng"],"note":["Gesehen am 27.05.2022"]}],"origin":[{"dateIssuedKey":"2024","dateIssuedDisp":"November, 2024"}],"title":[{"title_sort":"Late-onset NPM1 mutation in a MYC-amplified relapsed/refractory acute myeloid leukemia patient treated with gemtuzumab ozogamicin and glasdegib","title":"Late-onset NPM1 mutation in a MYC-amplified relapsed/refractory acute myeloid leukemia patient treated with gemtuzumab ozogamicin and glasdegib"}],"note":["Gesehen am 02.06.2025"],"language":["eng"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"recId":"1927251044","physDesc":[{"noteIll":"Illustrationen","extent":"5 S."}]} 
SRT |a JARAMILLOSLATEONSETN2024